Treato releases third version of flagship patient intelligence platform

Treato, the world's most comprehensive source of real-time patient voice insights, today announced the release of version 3 of its flagship patient intelligence platform. As part of the version release, the name of the product will change from Treato Pharma to Treato IQ reflecting the company's expanding focus on delivering targeted, quantifiable intelligence about patient perceptions, needs and behavior to health-focused market segments.

Treato IQ delivers deep insight into first-hand patient and caregiver experiences collected from the social web to inform ongoing decision-making across pharma business teams - from marketing, to product development, commercialization and safety. Customers can access actionable, real-time insights at both the brand- and condition-level based on billions of online conversations to better understand patient journey turning points, comparative medication efficacy and safety, compliance drivers, competitive perceptions, and unmet treatment needs.

"The healthcare industry, and pharmaceutical business specifically, are becoming increasingly focused on the patient as an end-customer through a changing policy, technology and regulatory landscape," said Ido Hadari, CEO of Treato. "Being able to bring the voices of these patients, en mass and in a timely manner, into every business decision is critical to driving ongoing pharma success. Based on what we've learned from our customers, Treato IQ now goes further and deeper to helping industry players gain the immediate patient insights they need to learn about and act upon."

According to latest Pew Research survey results, 72% of US adults use the Internet to find health information; additional research from Kantar Media shows a growing number of them are using the Internet to share and discuss their personal experiences across social media. Treato partners with both pharmaceutical companies and their agencies to provide targeted social health analytics solutions based on those conversations.

According to Henry Lee, Head of Strategic Insights and Analytics and Senior Vice President, Executive Director at Southern California-based PACIFIC Communications, "Fully understanding the dynamic factors that inform, influence, and enable consumers and patients throughout their journey of awareness to treatment is critical to serving our clients' strategic marketing needs for patients and healthcare professionals. Deep-sourced tools like Treato IQ enable us to deliver total brand solutions that take the voices of informed and engaged patients into account as these needs evolve." PACIFIC Communications is the largest full-service healthcare agency on the West Coast.

Version 3 Treato IQ updates include:

• Extended data coverage: tens of thousands of social media sources, from top popular destinations (e.g. Facebook & Tumblr) to targeted health forums & blogs
• Deeper drug journey insights: unprecedented analysis of patient treatment starts, stops and switching behavior, including reasons for therapy change
• Advanced patient segmentation: deep & actionable user breakdown by parameters such as gender, location and author type (patient vs. caregiver)
• Customized data analysis & support tools: powerful new tools including: filters for viewing data points according to select preferences, and email alerts for monitoring patient discussions about topics of interest
• New Twitter module: real time monitoring of brand sentiment, including brand mentions, top trending topics and top patient influencers
• Built-in AE management and reporting: dedicated tool enables flagging, forwarding and tracking relevant patient posts to comply with company pharmacovigilance protocol